Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Docking and Molecular Dynamics Simulations Clarify Binding Sites for Interactions of Novel Marine Sulfated Glycans with SARS-CoV-2 Spike Glycoprotein.
Samanta P
,
Mishra SK
,
Pomin VH
,
Doerksen RJ
.
Abstract
The entry of SARS-CoV-2 into the host cell is mediated by its S-glycoprotein (SGP). Sulfated glycans bind to the SGP receptor-binding domain (RBD), which forms a ternary complex with its receptor angiotensin converting enzyme 2. Here, we have conducted a thorough and systematic computational study of the binding of four oligosaccharide building blocks from novel marine sulfated glycans (isolated from Pentacta pygmaea and Isostichopus badionotus) to the non-glycosylated and glycosylated RBD. Blind docking studies using three docking programs identified five potential cryptic binding sites. Extensive site-targeted docking and molecular dynamics simulations using two force fields confirmed only two binding sites (Sites 1 and 5) for these novel, highly charged sulfated glycans, which were also confirmed by previously published reports. This work showed the structural features and key interactions driving ligand binding. A previous study predicted Site 2 to be a potential binding site, which was not observed here. The use of several molecular modeling approaches gave a comprehensive assessment. The detailed comparative study utilizing multiple modeling approaches is the first of its kind for novel glycan-SGP interaction characterization. This study provided insights into the key structural features of these novel glycans as they are considered for development as potential therapeutics.
Allen,
Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.
2021, Pubmed
Allen,
Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.
2021,
Pubmed
Benton,
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion.
2020,
Pubmed
Bose,
Role of heparan sulfate in human parainfluenza virus type 3 infection.
2002,
Pubmed
Cao,
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.
2020,
Pubmed
Carino,
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain.
2020,
Pubmed
Casalino,
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein.
2020,
Pubmed
Chen,
Sequence determination and anticoagulant and antithrombotic activities of a novel sulfated fucan isolated from the sea cucumber Isostichopus badionotus.
2012,
Pubmed
,
Echinobase
Clausen,
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
2020,
Pubmed
Dwivedi,
Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection.
2021,
Pubmed
,
Echinobase
Fadda,
Molecular simulations of complex carbohydrates and glycoconjugates.
2022,
Pubmed
Fiorentini,
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020.
2021,
Pubmed
Friesner,
Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.
2006,
Pubmed
Friesner,
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.
2004,
Pubmed
Gong,
The glycosylation in SARS-CoV-2 and its receptor ACE2.
2021,
Pubmed
Gupta,
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy.
2021,
Pubmed
Guvench,
CHARMM additive all-atom force field for carbohydrate derivatives and its utility in polysaccharide and carbohydrate-protein modeling.
2011,
Pubmed
Halgren,
Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.
2004,
Pubmed
Hirsh,
AHA Scientific Statement: Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association.
2001,
Pubmed
Hirsh,
Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association.
2001,
Pubmed
Hsu,
Structural remodeling of SARS-CoV-2 spike protein glycans reveals the regulatory roles in receptor-binding affinity.
2023,
Pubmed
Huang,
CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data.
2013,
Pubmed
Humphrey,
VMD: visual molecular dynamics.
1996,
Pubmed
Jo,
CHARMM-GUI: a web-based graphical user interface for CHARMM.
2008,
Pubmed
Kearns,
Spike-heparan sulfate interactions in SARS-CoV-2 infection.
2022,
Pubmed
Kim,
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.
2020,
Pubmed
Kim,
SARS-CoV-2 evolved variants optimize binding to cellular glycocalyx.
2023,
Pubmed
Kim,
Fractionation of sulfated galactan from the red alga Botryocladia occidentalis separates its anticoagulant and anti-SARS-CoV-2 properties.
2022,
Pubmed
Kim,
GlycoGrip: Cell Surface-Inspired Universal Sensor for Betacoronaviruses.
2022,
Pubmed
Kim,
CHARMM-GUI ligand reader and modeler for CHARMM force field generation of small molecules.
2017,
Pubmed
Kirschner,
GLYCAM06: a generalizable biomolecular force field. Carbohydrates.
2008,
Pubmed
Lan,
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.
2020,
Pubmed
Lee,
CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field.
2016,
Pubmed
Lu,
OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space.
2021,
Pubmed
Luan,
Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations.
2021,
Pubmed
Maier,
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB.
2015,
Pubmed
Mallajosyula,
Molecular dynamics simulations of glycoproteins using CHARMM.
2015,
Pubmed
Maurya,
Structure, anti-SARS-CoV-2, and anticoagulant effects of two sulfated galactans from the red alga Botryocladia occidentalis.
2023,
Pubmed
Mishra,
Assessing the Performance of MM/PBSA, MM/GBSA, and QM-MM/GBSA Approaches on Protein/Carbohydrate Complexes: Effect of Implicit Solvent Models, QM Methods, and Entropic Contributions.
2018,
Pubmed
Morris,
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.
2009,
Pubmed
Mottarella,
Docking server for the identification of heparin binding sites on proteins.
2014,
Pubmed
Mourão,
Perspective on the use of sulfated polysaccharides from marine organisms as a source of new antithrombotic drugs.
2015,
Pubmed
Mycroft-West,
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.
2020,
Pubmed
Nagae,
3D structural analysis of protein O-mannosyl kinase, POMK, a causative gene product of dystroglycanopathy.
2017,
Pubmed
Nagarajan,
Rigorous analysis of free solution glycosaminoglycan dynamics using simple, new tools.
2020,
Pubmed
Nguyen,
Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2.
2022,
Pubmed
Paiardi,
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
2022,
Pubmed
Park,
CHARMM-GUI Glycan Modeler for modeling and simulation of carbohydrates and glycoconjugates.
2019,
Pubmed
Pomin,
Marine Non-Glycosaminoglycan Sulfated Glycans as Potential Pharmaceuticals.
2015,
Pubmed
Pomin,
Antimicrobial Sulfated Glycans: Structure and Function.
2017,
Pubmed
Pomin,
A Dilemma in the Glycosaminoglycan-Based Therapy: Synthetic or Naturally Unique Molecules?
2015,
Pubmed
Pomin,
Holothurian fucosylated chondroitin sulfate.
2014,
Pubmed
,
Echinobase
Samsonov,
Computational analysis of interactions in structurally available protein-glycosaminoglycan complexes.
2016,
Pubmed
Sanda,
N- and O-Glycosylation of the SARS-CoV-2 Spike Protein.
2021,
Pubmed
Schuurs,
Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain.
2021,
Pubmed
Shajahan,
Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2.
2020,
Pubmed
Shajahan,
Glycosylation of SARS-CoV-2: structural and functional insights.
2021,
Pubmed
Shang,
Cell entry mechanisms of SARS-CoV-2.
2020,
Pubmed
Shukla,
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry.
2001,
Pubmed
Singh,
Extension and validation of the GLYCAM force field parameters for modeling glycosaminoglycans.
2016,
Pubmed
Soares,
A unique fucosylated chondroitin sulfate type II with strikingly homogeneous and neatly distributed α-fucose branches.
2018,
Pubmed
,
Echinobase
Sun,
Well-Defined Heparin Mimetics Can Inhibit Binding of the Trimeric Spike of SARS-CoV-2 in a Length-Dependent Manner.
2023,
Pubmed
Tandon,
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
2021,
Pubmed
Tian,
Application of per-Residue Energy Decomposition to Design Peptide Inhibitors of PSD95 GK Domain.
2022,
Pubmed
Trott,
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
2010,
Pubmed
Tyagi,
Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans.
2001,
Pubmed
Uciechowska-Kaczmarzyk,
Docking software performance in protein-glycosaminoglycan systems.
2019,
Pubmed
Varki,
Biological roles of glycans.
2017,
Pubmed
Vasconcelos,
Marine Carbohydrate-Based Compounds with Medicinal Properties.
2018,
Pubmed
Vivès,
Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site.
2005,
Pubmed
Warkentin,
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.
1995,
Pubmed
Watanabe,
Site-specific glycan analysis of the SARS-CoV-2 spike.
2020,
Pubmed
Woo,
Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane.
2020,
Pubmed
Xie,
Revealing the mechanism of SARS-CoV-2 spike protein binding with ACE2.
2020,
Pubmed
Zhang,
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins.
2021,
Pubmed
Zoepfl,
Antiviral activities of four marine sulfated glycans against adenovirus and human cytomegalovirus.
2021,
Pubmed
,
Echinobase
Zong,
Anticancer polysaccharides from natural resources: a review of recent research.
2012,
Pubmed
